KRT18P55 (Gene)

Entrez:284085

Description:keratin 18 pseudogene 55

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View KRT18P55's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with KRT18P55.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using KRT18P55.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for KRT18P55.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KRT18P55.

Results found

Linked to

	Label	Description
	GSE113369 p53 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149049 FLT3 inhibition 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133661 C19orf12 knockdown A-549 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE112202 digoxin 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE149049 FLT3 inhibition 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 4 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 10 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE133661 C19orf12 knockdown A-549 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE112202 digoxin 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 9 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.